Home > Insider Trading > Filing (0001209191-11-003854)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509688	L Dean Schorno	301 Penobscot Drive Redwood City CA 94063	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-13	1,276	$2.88	21,276	No	4	M	Direct
Common Stock	Disposition	2011-01-13	1,276	$21.06	20,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-01-13	1,276	$0.00	1,276	$2.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-12-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,149	Indirect	By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA

Footnotes

The number of shares originally covered by the exercised option was 13,333 options at an exercise price per share of $3.00 per share. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 536 to 13,869, reducing the effective exercise price per share to $2.88.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on September 8, 2010.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $20.98 to $21.27.
The option became exercisable as to 25% of the shares on December 2, 2004, and became exercisable as to 1/48th of the shares each full month thereafter.